Barely Significant
← all excerpts

A randomised, controlled, feasibility trial comparing vasopressors infused via peripheral cannula versus central venous access for critically ill adults: The VIPCA trial.

Crit Care Resusc · 2025 · PMC12417211 · PMID 40933726

1
hedged sentence
closest p
boldest claim

The sentences

may be significantno p-value reported
Key findings Our findings demonstrate that protocol adherence was markedly different between the early CVC and late CVC groups, suggesting there may be significant equipoise issues that influence the timing of critical care clinicians’ choice to insert CVCs for the provision of vasopressor infusions.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.